Neurogenic inflammation: Difference between revisions
No edit summary |
Varun Kumar (talk | contribs) No edit summary |
||
Line 33: | Line 33: | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Low priority]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 20:28, 5 August 2011
Neurogenic inflammation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Neurogenic inflammation is a general term used to describe the local release of inflammatory mediators from afferent neurons such as substance P and calcitonin gene-related peptide.
Pathophysiology
This process appears to play an important role in the pathogenesis of numerous diseases including asthma, fibromyalgia, eczema, psoriasis and migraine.
External links
- Bronchial Asthma as Neurogenic Inflammatory Paroxysmal Disease Common neurogenic inflammatory mechanisms of asthma with migraine and trigeminal neuralgia.
- Psoriasis: Neurogenic inflammation and other mechanisms Psoriasis, a common inflammatory skin disorder.